Search for: "Mylan Inc."
Results 441 - 460
of 674
Sort by Relevance
|
Sort by Date
3 May 2011, 7:16 am
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
27 Apr 2011, 6:44 am
Mylan Pharmaceuticals, Inc., C.A. [read post]
26 Apr 2011, 11:15 pm
Along with Cardinal Health 409 and Mylan Inc., Genpharm could be among the generic drugmaker defendants in the consolidated Accutane lawsuits. [read post]
15 Apr 2011, 6:02 am
Mylan Pharmaceuticals, Inc., 2009 WL 7115134, at *2 (N.D. [read post]
11 Apr 2011, 8:33 am
In Mylan Pharmaceuticals Inc. v. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
25 Mar 2011, 8:29 pm
Mylan Labs., Inc., 464 F.3d 1286, 1295 (Fed. [read post]
25 Mar 2011, 11:43 am
Mylan Labs., Inc., 464 F.3d 1286, 1295 (Fed. [read post]
25 Mar 2011, 11:43 am
Mylan, Inc., 661 F. [read post]
24 Mar 2011, 12:53 pm
Note: Goldstein, Howe & Russell, P.C. serves as counsel to the petitioners in the following case, which is listed without regard to its likelihood of being granted.Title: Kaiser Eagle Mountain, Inc. v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
14 Mar 2011, 8:12 pm
(forthcoming)Motion for leave to file out of time amicus brief of American Bankers AssociationPetitioner's reply Title: Mylan Inc. v. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
1 Mar 2011, 8:38 pm
Roche Molecular Systems, Inc. [read post]
27 Feb 2011, 8:59 pm
Mylan Inc. et al. 1:11-cv-01285; filed February 23, 2010 in the Northern District of Illinois • Plaintiff: The Medicines Company • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.; Bioniche Pharma USA, LLC Infringement of U.S. [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) –… [read post]
13 Feb 2011, 9:08 pm
Mylan Pharmaceuticals Inc. et al. 1:11-cv-00127; filed February 10, 2011 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
